Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name? [0.03%]
冠状动脉无事件或家族性高胆固醇耐受性：名字背后的意义是什么？
Seyed Saeed Tamehri Zadeh,Dick C Chan,Pedro Mata et al.
Seyed Saeed Tamehri Zadeh et al.
Purpose of review: Familial hypercholesterolemia (FH) is an autosomal semi-dominant condition, characterized by excessive circulating low-density lipoprotein cholesterol (LDL-C) from birth that substantially accelerates t...
Advances in assessment and treatment of bone, mineral and parathyroid disorders [0.03%]
骨、矿物质及甲状旁腺紊乱的评估和治疗进展
Samuel D Vasikaran
Samuel D Vasikaran
Eugene McCloskey,Andre T H Tan,Marian Schini
Eugene McCloskey
Purpose of review: The assessment of fracture risk is playing an ever-increasing role in osteoporosis clinical management and informing international guidelines for osteoporosis. FRAX, a fracture risk calculator that prov...
Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis [0.03%]
骨转换生物标志物潜力的洞察：在骨质疏松症和慢性肾脏病相关性骨质疏松症管理中的整合
Pauline Brouwers,Antoine Bouquegneau,Etienne Cavalier
Pauline Brouwers
Purpose of review: Disturbances in mineral and bone metabolism occurring in osteoporosis and chronic kidney disease-associated osteoporosis place patients at high risk of fracture making these conditions a major public he...
Cherie Chiang
Cherie Chiang
Purpose of review: Since the release of the 2022 Second International Workshop Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines, updates and advances are now available in the cause, complic...
The use of anabolic agents in the treatment of osteoporosis: a clinical update [0.03%]
雄激素类药物治疗骨质疏松症的临床应用进展
Charles A Inderjeeth,Diren C Inderjeeth
Charles A Inderjeeth
Purpose of review: Anabolic therapies have revolutionized the management of patients with osteoporosis, especially those at very high fracture risk. The current review offers valuable insights into the latest evidence and...
Manuel Jesús Romero-Jiménez,María Elena Mansilla-Rodríguez
Manuel Jesús Romero-Jiménez
Purpose of review: Familial Hypercholesterolemia is associated with an increased risk of cardiovascular disease. The current international guidelines of the main scientific societies consider that all people with familial...
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders [0.03%]
与纤维细胞生长因子23相关的低磷血症相关疾病的新进展
Yuichi Takashi,Daiji Kawanami,Seiji Fukumoto
Yuichi Takashi
Purpose of review: Fibroblast growth factor 23 (FGF23) is a hormone to reduce blood phosphate concentration. Excessive actions of FGF23 induce FGF23-related hypophosphatemic disorders, such as X-linked hypophosphatemic ri...
Francesco Inchingolo,Angelo Michele Inchingolo,Fabio Piras et al.
Francesco Inchingolo et al.
Purpose of review: This review critically examines interconnected health domains like gut microbiome, bone health, interleukins, chronic periodontitis, and coronavirus disease 2019 (COVID-19), offering insights into funda...
Khushboo Gala,Wissam Ghusn,Barham K Abu Dayyeh
Khushboo Gala
Purpose of review: Metabolic and bariatric surgery (MBS) and endoscopic bariatric therapies (EBT) are being increasingly utilized for the management of obesity. They work through multiple mechanisms, including restriction...